Ketamine for Psychiatric Indications: from the lab to the clinic
April 7 @ 8:00 pm - 9:30 pm CEST
Dr. Levine will provide an overview of the early translation of research on ketamine for depression to real-world application in private clinics across the United States, its evolution over the past decade, and implications as a new model of psychiatric care deliver.
THE EVENT SPEAKER(s):
Steve Levine, MD
Psychiatrist, VP of Patient Access at COMPASS Pathways
Dr. Steve Levine is a board-certified psychiatrist and VP of Patient Access at COMPASS Pathways, as well as co-founder and chairman of the board of Heading Health.View full profile ››